NasdaqHealth CareSurgical & Medical Instruments & ApparatusMIAMI, FL

InspireMD Inc. NSPR

Ask your AI

Estimated market cap $29.94M46.49M shares, shares as of Aug 14, 2026CIK 1433607

Insider trades, 12 mo

14 buys · 12 sells

$126.9K sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

21.5% of shares · 2 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in InspireMD Inc.'s latest quarterly report, compared with the one before.

Filed Aug 14, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: risk factors and legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in InspireMD Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

26 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since May 27, 2026. Insiders have two business days to file.

Recent insider trades

Paul Stuka Director	May 27 Form 4 ↗	Buy	+$17.6K 20,000 sh @ $0.88	-27.3%
Shane Thomas Gleason Chief Commercial Officer	May 19 Form 4 ↗	Sale	−$23.0K 22,778 sh @ $1.01	-38.4%
Shane Thomas Gleason Chief Commercial Officer	Feb 2 Form 4 ↗	Sale	−$4,676 2,941 sh @ $1.59	-69.0%
Shane Thomas Gleason Chief Commercial Officer	May 30, 2025 Form 4 ↗	Sale	−$18.0K 7,186 sh @ $2.51	-102.8%
Shane Thomas Gleason Chief Commercial Officer	May 29, 2025 Form 4 ↗	Sale	−$9,438 3,760 sh @ $2.51	-102.7%

All NSPR insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

9.98M shares

23 funds report NSPR. Values checked against market prices.

Funds own 54% of shares (Q2 2026)

38 funds hold the stock.

Q3 2026: 21% · 5,560 of ~8,900 funds reported so far

Q2 202534%
Q3 202554%
Q4 202555%
Q1 202649%
Q2 202654%
Q3 2026 (so far)21%

Q3 2026. 2 new, 2 added to, 7 trimmed, 17 exited since Q2 2026.

Top 13F holders
#
1	Aberdeen Group plc 13F ↗	3.70M	$2.5M	unchanged
2	Nantahala Capital Management, LLC 13F ↗	3.38M	$2.3M	-50.0%
3	Marshall Wace, LLP 13F ↗	1.86M	$1.2M	unchanged
4	Ingalls & Snyder LLC 13F ↗	362,550	$242.0K	-1.7%
5	UBS Group AG 13F ↗	133,653	$89.3K	+2415.1%
6	BlackRock, Inc. 13F ↗	117,708	$78.6K	-4.3%
7	Creative Planning 13F ↗	108,964	$72.8K	unchanged
8	Renaissance Technologies LLC 13F ↗	87,892	$58.7K	-22.1%
9	Mesirow Financial Investment Management, Inc. 13F ↗	30,000	$20.0K	unchanged
10	Centiva Capital, LP 13F ↗	27,180	$18.2K	-38.4%

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds NSPR, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What InspireMD Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What InspireMD Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q2 2021	15	—	450,833	$2.3M
Q3 2021	13	-2	170,104	$703.5K
Q4 2021	20	+7	183,945	$561.3K
Q1 2022	18	-2	141,162	$456.5K
Q2 2022	16	-2	129,500	$259.2K
Q3 2022	15	-1	112,764	$168.6K
Q4 2022	15	0	155,865	$137.2K
Q1 2023	14	-1	89,975	$104.1K
Q2 2023	22	+8	8.05M	$20.2M
Q3 2023	25	+3	8.76M	$28.7M
Q4 2023	28	+3	12.47M	$35.0M
Q1 2024	27	-1	10.31M	$24.3M
Q2 2024	24	-3	13.98M	$34.9M
Q3 2024	28	+4	12.40M	$33.2M
Q4 2024	30	+2	12.71M	$33.4M
Q1 2025	36	+6	12.93M	$34.8M
Q2 2025	37	+1	14.07M	$31.9M
Q3 2025	42	+5	22.74M	$54.8M
Q4 2025	46	+4	23.18M	$41.2M
Q1 2026	36	-10	22.81M	$37.2M
Q2 2026	38	+2	24.93M	$17.5M
Q3 2026	23	-15	9.98M	$6.7M

Each point is a quarter-end, from Q2 2021 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (45779A846). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2021) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes6 in 12 mo 8-K events4 in 90 days Patents2 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive pay3 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials3 active FDA decisionsLatest Jun 23 IPO history6 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: InspireMD, Inc.
Address: 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL 33126
Phone: (888) 776-6804
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: NSPR (Nasdaq)
Former names: Saguaro Resources, Inc. (until 2011)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.6441−$0.13 (−16.78%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.4385 · High $0.80Nov 13, 2026

Aug 13, 2026Low $0.4385 · High $0.9824Nov 13, 2026

Nov 13, 2025Low $0.4385 · High $2.15Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.